VEGF-D is a serum biomarker for the LAM diagnosis that, when above the threshold of 800 pg/mL, helps to distinguish LAM from other lung diseases with a specificity of 100% and a sensibility of 58% [170, 171]. Here, VEGFD is linked to lymphangioleiomyomatosis.